Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Numinus Wellness Inc T.NUMI

Alternate Symbol(s):  NUMIF

Healthcare
Numinus Wellness Inc. is a mental health care company. The Company focuses on advancing traditional and behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies. Its segments include Clinical research operations, Practitioner Training, Clinic network, and Corporate. Clinical research operations segment is focused on licensed psychedelic research and... see more

Recent & Breaking News (TSX:NUMI)

Numinus Wellness Inc. (TSX:NUMI) acquires Novamind and announces executive appointments

John Ballem  June 13, 2022

Numinus completes acquisition of Novamind and announces executive appointments

PR Newswire June 10, 2022

Novamind Obtains Final Order for Plan of Arrangement from the Supreme Court of British Columbia and Completes Acquisition by Numinus Wellness Inc.

Accesswire June 10, 2022

Numinus announces shareholder approval of resolution in connection with the proposed acquisition of Novamind

PR Newswire June 8, 2022

Numinus announces ISS recommends shareholders vote in favor of the share issuance to acquire Novamind

PR Newswire May 31, 2022

Numinus Wellness Receives Health Canada Special Access Program Applicant Approval to Provide Psychedelic-assisted Therapy Treatment

PR Newswire May 16, 2022

Numinus to Participate in the H.C. Wainwright Global Investment Conference on May 23-26, 2022

PR Newswire May 11, 2022

Numinus Mails Materials for Special Meeting of Shareholders and Announces Interim Court Order for Plan of Arrangement

PR Newswire May 10, 2022

Numinus to Participate in Upcoming Research & Industry Conferences

PR Newswire May 9, 2022

Numinus Announces the Music as Medicine Event Series

PR Newswire April 29, 2022

The StockTalk Cannabis Report: April 15, 2022

Dave Jackson April 15, 2022

Numinus Wellness Inc. Reports Q2 2022 Results

PR Newswire April 14, 2022

North America’s New Industry Leader in Psychedelic Therapy & Research

Stockhouse Editorial April 12, 2022

IIROC Trade Resumption - NUMI

Canada NewsWire April 12, 2022

IIROC Trading Halt - NUMI

Canada NewsWire April 11, 2022

Numinus to Participate in Upcoming Investor Conferences in April 2022

PR Newswire April 7, 2022

Numinus to Host Q2 2022 Results Conference Call on April 14, 2022

PR Newswire April 1, 2022

Numinus Completes First MDMA Administration in PTSD Trial Sponsored by MAPS

PR Newswire March 30, 2022

Numinus to Participate in Maxim's 2022 Virtual Growth Conference on March 28-30, 2022

PR Newswire March 15, 2022

Numinus Expands Natural Psychedelic Research with New Biosecurity License

PR Newswire March 14, 2022